Matisse Capital SPRY Holdings History
Matisse Capital's ARS Pharmaceuticals Inc Holding Summary
As of 2025-06-30, Matisse Capital held 56,714.00 shares of ARS Pharmaceuticals Inc(SPRY), totaling $989,660.00. This investment constitutes 0.47% of their stock portfolio, and Matisse Capital now holds 0.06% of the outstanding ARS Pharmaceuticals Inc(SPRY) stock.
The initial trade took place in 2025Q1. And since then Matisse Capital has made 2 purchases of SPRY, at an average price of $12.07, for a total of 56,714.00 shares. Based on historical transaction data and SPRY's current price of $18.00, Matisse Capital's estimated gain on his SPRY holdings is $336,212.58, reflecting a 49.11% gain to date.
Matisse Capital SPRY ($18.00) Holding Chart
Matisse Capital SPRY ($18.00) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
